Form 4: Illumina Director Scott Ullem Receives Stock Grant

Illumina, Inc. director Scott B. Ullem was granted 2,072 restricted stock units as part of his director compensation.

Summary

• Director Scott B. Ullem acquired 2,072 shares of Illumina, Inc. (ILMN) common stock via a restricted stock unit (RSU) grant.
• The transaction occurred on May 21, 2026, at a valuation of $144.83 per share.
• Following this transaction, the director's total beneficial ownership increased to 10,863 shares.
• The RSU grant is subject to a one-year vesting schedule tied to the director's continued service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation that does not signal a change in company strategy or financial health.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Increase in total beneficial ownership by a member of the board.

Negatives

• None identified; this is a standard director compensation event.

Risks

• Vesting is contingent upon continued service as a director.

Future Outlook

The RSU grant vests on the earlier of the one-year anniversary of the grant or the date immediately preceding the next annual stockholders' meeting, provided the director remains in service.

Industry Context

StockSavvy.ai notes that equity-based compensation for board members is a standard corporate governance practice in the biotechnology and life sciences sector to ensure long-term alignment with shareholder value.

Comparison to Industry Standards

• The grant of restricted stock units to non-employee directors is consistent with standard compensation practices for S&P 500 companies.
• The one-year vesting period aligns with typical industry benchmarks for director equity retention.

Stakeholder Impact

• Minimal impact on shareholders; reflects standard director compensation.

Next Steps

• Vesting of the 2,072 restricted stock units on the earlier of the one-year anniversary or the next annual meeting.

Key Dates

Keywords

Illumina, ILMN, Form 4, Insider Trading, Director Compensation, Equity Grant